Summary
Latest filing:
Lisa A. Conte is Chief Exec. Officer & President of Jaguar Health, Inc. (JAGX). 5 SEC Form 4 filings on record going back to 2024, most recently on 21 January 2026. Lifetime open-market purchases: $450.00M.
Recent Transactions
3Every recent SEC Form 4 transaction Lisa A. Conte has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Lisa A. Conte. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James J. Bochnowski - $4.05B of JAGX open-market activity on record
- John Micek - $450.00M of JAGX open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Lisa A. Conte?
Lisa A. Conte is a corporate insider, tracked as Chief Exec. Officer & President of Jaguar Health, Inc. (JAGX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Lisa A. Conte last file a Form 4?
The most recent primary Form 4 on record is dated 21 January 2026, one of 5 filings going back to 2024.
Has Lisa A. Conte been buying or selling stock?
Recorded transactions: 2 open-market purchases ($450.00M) and 0 open-market sales across all tracked filings.
Where can I see all of Lisa A. Conte's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Lisa A. Conte and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
